The Request for Proposal Submission process for a Competitive Grants Program promoted by Pfizer, in the amount of US $ 400 thousand, is ongoing. Submissions considered for funding should be focused on the development of accredited educational activities in the area of Oncology - Hematology - Chronic Myeloid Leukemia (CML). Projects must be submitted by 7th April, 2020.
Only proposals submitted by the indicated deadlines will be accepted. Subsequently, the projects will be analyzed by a panel of independent reviewers, who will select the projects for funding. Pfizer has no influence on any aspect of the projects and only requests reports on the results and on the impact of the projects in order to share them publicly.
These grants are part of the Pfizer Global Medical Grants (GMG) program, created to support independent initiatives, with the aim of improving health outcomes and responding to unmet medical needs, in line with Pfizer's scientific strategy.
More information at, Patient Education in Chronic Myeloid Leukemia (CML)